Brazil cranks up malaria diagnostics access with new campaign
This article was originally published in Clinica
Brazil has launched a malaria awareness campaign that aims to build primarily on the early successes of an ongoing initiative to increase access to testing. The drive to ensure prompt diagnostic confirmation and appropriate treatment is described by the government as being on a par with avoiding infection in the first place.
You may also be interested in...
The amyloid-targeting drug is years behind Biogen/Eisai’s aducanumab, but its subcutaneous administration and the GRADUATE studies’ design could give Roche’s gantenerumab an advantage.
Correvio's atrial fibrillation drug Brinavess will return to a US FDA advisory committee more than a decade after the agency first declined to approve the drug; FDA still has a series of cardiovascular safety concerns related to the drug and is not convinced by data from the European experience.
FerGene bladder cancer therapy achieved a complete response in more than half of patients in its pivotal trial. The joint venture now looks to commercialization and potential expansion of indications.